AbstractHIVRSVInternational Workshop on HIV & Women 2019We Can Do It! Addressing Intimate Partner Violence in HIV Research with WomenView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Adherence and Retention in Care Among Female Sex Workers in an HIV Pre-Exposure Prophylaxis (PrEP) Clinic, Kampala, UgandaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Treatment of HIV-Related Cryptococcosis in Pregnancy and the Post-Partum PeriodView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Impact of Sex on Cryptococcal Meningitis Mortality in Uganda and South AfricaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Development and Piloting of a Scale to Measure Trauma- and Violence-Aware Principles of HIV Care and Practice for Women Living with HIV in Metro Vancouver, CanadaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Depression Symptom Trajectories Among Mothers Living with HIV in Rural UgandaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Risk of Hospitalisation According to Gender and Ethnicity Among People Living with HIV in the Modern ART EraView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 201938% of Child Bearing Women with HIV in the UK Would Like to Breastfeed--Results from PACIFY Study GroupView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Reflections on a Specialist HIV Menopause ServiceView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Prevalence of Cervical Dysplasia in HIV-Positive Women Versus HIV-Negative Women: The Case of ZambiaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Efficacy and Safety of the Once-Daily Darunavir /Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Single-Tablet Regimen in Antiretroviral Treatment (ART)-Experienced and ART-Naïve Women Living with HIV-1: EMERALD and AMBER Week 96 ResultsView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Week 48 Safety and Efficacy of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Women in the BRIGHTE StudyView Abstract
